VIATRIS INC (VTRS) Stock Price, Quote, News and Overview
NASDAQ:VTRS - Nasdaq - US92556V1061 - Common Stock - Currency: USD
VTRS Quote, Performance and Key Statistics
VIATRIS INC
NASDAQ:VTRS (1/28/2025, 8:11:24 PM)
After market: 11.2 0 (0%)11.2
-0.22 (-1.93%)
The current stock price of VTRS is 11.2 USD. In the past month the price decreased by -10.83%. In the past year, price decreased by -5.49%.
VTRS Latest News, Press Releases and Analysis
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.
What's going on in today's session: S&P500 movers
Top movers analysis in the middle of the day of S&P500 on 2025-01-15: top gainers and losers in today's session.
Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
These S&P500 stocks are gapping in today's session
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions.
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in...
VTRS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.15 | 764.19B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.4 | 378.36B | ||
| JNJ | JOHNSON & JOHNSON | 15.05 | 362.06B | ||
| MRK | MERCK & CO. INC. | 16.38 | 246.51B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.27 | 215.81B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.65 | 203.61B | ||
| PFE | PFIZER INC | 10.37 | 151.59B | ||
| SNY | SANOFI-ADR | 12.52 | 132.81B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.22 | 119.18B | ||
| ZTS | ZOETIS INC | 29.59 | 76.89B | ||
| GSK | GSK PLC-SPON ADR | 8.4 | 71.61B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.92 | 42.39B |
Related stock screener links
About VTRS
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. The company is headquartered in Canonsburg, Pennsylvania and currently employs 38,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The firm operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Company Info
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA 15317 US
CEO: Michael Goettler
Employees: 33000
Company Website: https://www.viatris.com/en
Investor Relations: https://investor.viatris.com/
Phone: 17245141800
VTRS FAQ
What is the stock price of VTRS?
The current stock price of VTRS is 11.2 USD.
What is the symbol for VIATRIS INC stock?
The exchange symbol of VIATRIS INC is VTRS and it is listed on the Nasdaq exchange.
On which exchange is VTRS stock listed?
VTRS stock is listed on the Nasdaq exchange.
Is VTRS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VTRS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VTRS.
Does VTRS stock pay dividends?
VTRS has a dividend yield of 4.31%. The yearly dividend amount is currently 0.48.
What is the Price/Earnings (PE) ratio of VTRS?
The PE ratio for VTRS is 4.1. This is based on the reported non-GAAP earnings per share of 2.73 and the current share price of 11.2 USD.
What is the Short Interest ratio of VTRS stock?
The outstanding short interest for VTRS is 2.89% of its float.
VTRS Technical Analysis
VTRS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VTRS. VTRS has a medium profitability rating, but doesn't score so well on its financial health evaluation.
VTRS Financial Highlights
Over the last trailing twelve months VTRS reported a non-GAAP Earnings per Share(EPS) of 2.73. The EPS decreased by -8.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.97% | ||
| ROE | -4.46% | ||
| Debt/Equity | 0.72 |
VTRS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 55% to VTRS. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of -6.55% and a revenue growth -3.97% for VTRS